Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at ZAR 1.49T, ahead of Johnson & Johnson (ZAR 1.4T) and Sanofi (ZAR 1.36T). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerZAR 1.49T
- Median
- ZAR 15.1B
- Combined market value
- ZAR 88.79T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | ZAR 1.49T | ZAR 2.79T | ZAR 490.06 | 1.35% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | ZAR 1.4T | ZAR 11.55T | ZAR 4,797.35 | 1.36% down | 38% up | ||
| 3 | SanofiSNY · Health Care | ZAR 1.36T | ZAR 1.96T | ZAR 818.15 | 1.78% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | ZAR 905.5B | ZAR 6.08T | ZAR 2,467.87 | 0.75% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | ZAR 897.3B | ZAR 3.12T | ZAR 1,802.40 | 2.55% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | ZAR 837.7B | ZAR 4.87T | ZAR 3,137.47 | 0.95% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | ZAR 800.9B | ZAR 1.19T | ZAR 372.50 | 0.23% up | 54% up | ||
| 8 | NovartisNVS · Health Care | ZAR 794B | ZAR 5.17T | ZAR 2,739.15 | 0.67% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 538B | ZAR 1.71T | ZAR 16,486.21 | 0.56% up | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | ZAR 495.7B | ZAR 3.09T | ZAR 700.58 | 2.16% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | ZAR 456.8B | ZAR 21.7T | ZAR 24,366.29 | 1.13% down | 35% up | ||
| 12 | GSKGSK · Health Care | ZAR 374.2B | ZAR 1.7T | ZAR 847.58 | 2.32% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 321.3B | ZAR 2.33T | ZAR 9,195.34 | 0.67% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | ZAR 318B | ZAR 2.16T | ZAR 1,056.04 | 2.51% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | ZAR 253.2B | ZAR 403.6B | ZAR 352.01 | 1.40% down | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | ZAR 167.2B | ZAR 679.8B | ZAR 1,182.21 | 0.23% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 136.2B | ZAR 856B | ZAR 733.63 | 0.12% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | ZAR 122.1B | ZAR 428.2B | ZAR 10,054.29 | 0.64% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | ZAR 112.7B | ZAR 222.4B | ZAR 444.96 | 2.12% down | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 104.8B | ZAR 195.1B | ZAR 1,007.15 | 0.90% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | ZAR 100.7B | ZAR 101.1B | ZAR 148.55 | 1.15% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | ZAR 100.6B | ZAR 551.5B | ZAR 894.40 | 0.76% up | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | ZAR 77.9B | ZAR 482.8B | ZAR 666.33 | 0.26% up | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | ZAR 75.1B | ZAR 812.6B | ZAR 7,113.57 | 0.48% up | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 74.3B | ZAR 266B | ZAR 4,143.41 | 0.39% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 69.1B | ZAR 212.2B | ZAR 254.58 | 0.61% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | ZAR 57.3B | ZAR 583.9B | ZAR 1,436.97 | 1.08% down | 29% down | ||
| 28 | AlkermesALKS · Health Care | ZAR 31.3B | ZAR 131.5B | ZAR 782.34 | 2.32% down | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | ZAR 17.5B | ZAR 101.2B | ZAR 5,057.44 | 2.62% down | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | ZAR 17.2B | ZAR 53.8B | ZAR 277.31 | 0.75% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | ZAR 15.1B | ZAR 146.8B | ZAR 5,251.09 | 1.68% down | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 13.6B | ZAR 360.8B | ZAR 2,693.88 | 2.02% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | ZAR 13.3B | ZAR 110.3B | ZAR 2,714.88 | 2.98% down | 31% up | ||
| 34 | InsmedINSM · Health Care | ZAR 12.7B | ZAR 460.2B | ZAR 2,097.61 | 0.83% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | ZAR 12.3B | ZAR 153.4B | ZAR 1,614.78 | 5.60% down | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | ZAR 11.3B | ZAR 146.9B | ZAR 183.67 | 9.73% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | ZAR 11.2B | ZAR 163.2B | ZAR 1,079.45 | 0.08% down | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | ZAR 11.2B | ZAR 132B | ZAR 1,206.14 | 1.23% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | ZAR 11B | ZAR 83.4B | ZAR 479.39 | 1.49% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | ZAR 10.6B | ZAR 140.1B | ZAR 2,145.98 | 0.13% down | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 10.4B | ZAR 168.7B | ZAR 7,263.84 | 0.46% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 9.8B | ZAR 128.6B | ZAR 1,637.16 | 0.93% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9B | ZAR 79.2B | ZAR 723.65 | 3.75% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | ZAR 8.7B | ZAR 123.7B | ZAR 1,413.21 | 1.81% down | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | ZAR 8.5B | ZAR 84.3B | ZAR 1,497.21 | 2.87% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | ZAR 8.4B | ZAR 77.3B | ZAR 464.07 | 3.75% down | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | ZAR 8.1B | ZAR 112.4B | ZAR 1,657.99 | 2.94% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 8B | ZAR 104.6B | ZAR 740.00 | 2.76% down | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | ZAR 5.7B | ZAR 69.2B | ZAR 505.73 | 2.59% down | 169% up | ||
| 50 | ErascaERAS · Health Care | ZAR 5.6B | ZAR 83.9B | ZAR 239.09 | 8.07% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.4B | ZAR 103.3B | ZAR 1,582.76 | 0.40% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 2.4B | ZAR 139.2B | ZAR 2,007.24 | 8.49% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | ZAR 2B | ZAR 84.4B | ZAR 879.60 | 2.82% up | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | ZAR 1.5B | ZAR 123.1B | ZAR 2,340.15 | 0.77% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -ZAR 1.2B | ZAR 126.7B | ZAR 363.54 | 0.52% down | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -ZAR 2.1B | ZAR 91.3B | ZAR 2,162.68 | 1.88% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -ZAR 3.1B | ZAR 306.2B | ZAR 4,668.07 | 0.20% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -ZAR 3.5B | ZAR 86.8B | ZAR 1,038.99 | 1.00% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -ZAR 11.4B | ZAR 123.8B | ZAR 889.07 | 2.86% down | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -ZAR 35.9B | ZAR 257.5B | ZAR 1,321.98 | 0.72% down | 17% up | ||
| 61 | AbbVieABBV · Health Care | -ZAR 56.3B | ZAR 8.91T | ZAR 5,040.40 | 0.59% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2133 ZAR).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (ZAR 1.49T), Johnson & Johnson (ZAR 1.4T) and Sanofi (ZAR 1.36T) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 14:23 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of ZAR 88.79T as of 18 Nov 2026, 14:23 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.